Why Does Immunotherapy Not Always Work? New Research Sheds Light
New research sheds light on the molecular processes determining the responsiveness of certain cancers to immunotherapy. A new study has shed light on why immunotherapy…
EMBL-EBI News
The “Long Read” for Cancer: A New, Broader Genomic View
Researchers seeking to gain deeper insights into the relationship between DNA mutations and cancer through genomics sequencing utilized a long-read approach to obtain a more…
Researchers Uncover New Insight Into Rare Eye Disorders
Researchers at EMBL-EBI delve into the UK Biobank data to uncover new information about rare diseases of the eye. Researchers have conducted a thorough examination…
Interacting Human Protein Map Prioritizes New Targets for Drug Discovery From Shared Basis of Diseases
Scientists at Open Targets, the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI), and GSK are revealing the shared basis of diseases using a map…
DeepMind AI Powers Major Scientific Breakthrough: AlphaFold Generates 3D View of the Protein Universe
AI-powered predictions of the three-dimensional structures of nearly all cataloged proteins known to science have been made by DeepMind and EMBL’s European Bioinformatics Institute (EMBL-EBI)….
Scientists Unravel the Origins of the Human Spine
Scientists at EMBL Barcelona have recapitulated in the laboratory for the first time how the cellular structures that give rise to our spinal column form…
Tackling the Collateral Damage to Our Health From Antibiotics
EMBL scientists pave the way for reducing the harmful side effects antibiotics have on gut bacteria. Antibiotics help us to treat bacterial infections and save…
Researchers Reset Human Pluripotent Stem Cells to a Fully Pristine State
A newly published study details how scientists were able to successfully ‘reset’ human pluripotent stem cells to a fully pristine state. Researchers at EMBL-EBI have…